EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-Metaanalyse

Safety and efficacy of drug‐eluting stents for patients at high risk of bleedings: A network meta‐analysis

Federico Giacobbe iD, Eduardo Valente iD, Arianna Morena, Marco Nebiolo, Giuseppe Giannino, Ovidio De Filippo iD, Francesco Bruno, Elena Isaevska, Lorenzo Richiardi, Mario Iannaccone iD, Giuseppe Biondi Zoccai iD, Francesco Burzotta iD und 2 weitere

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31047 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Federico Giacobbe und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Cardiovascular and Thoracic Department, "Città della Salute e della Scienza" Hospital, Turin, Italy. Hauptthemen laut MEDLINE: Coronary Artery Disease, Drug-Eluting Stents, Hemorrhage, Percutaneous Coronary Intervention. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Among different coronary stents implanted in High Bleeding Risk (HBR) patients with an indication for short antiplatelet therapy, no comparisons in terms of efficacy have been provided.

Methods

A Network Meta Analysis was performed including all randomized controlled trials comparing different coronary stents evaluated in HBR patients. Major Adverse Cardiovascular Events (MACEs) as defined by each included trial were the primary end point, whereas TLR (target lesion revascularization), TVR (target vessel revascularization), stent thrombosis and total and major (BARC3‐5) bleedings were the secondary ones.

Results

A total of four studies (ONYX ONE, LEADERS FREE, SENIOR and HBR in BIO‐RESORT) including 6637 patients were analyzed with different kind of stents and dual antiplatelet therapy (DAPT) length (1 or 6 months) on 12 months follow‐up. About one‐third of these patients were defined HBR due to indication for oral anticoagulation. All drug eluting stents (DESs) reduced risk of MACE compared to Bare Metal Stents (BMSs) when followed by a 1‐month DAPT. At SUCRA analysis, Orsiro was the device with the highest probability of performing best. Rates of TLR and TVR were significantly lower when using Resolute Onyx, Synergy and BioFreedom stents in comparison to BMS when followed by 1‐month DAPT, with Synergy ranking best. Synergy also showed a significantly lower number of stent thrombosis compared to BMS (RR 0.28, 95% CI 0.06−0.93), while Orsiro and Resolute Integrity showed the highest probability of performing best.

Conclusion

In HBRs patients, all DESs were superior to BMSs in terms of efficacy and safety. Among DESs, Orsiro was the one with the highest ranking in terms of MACE, mainly driven by a reduced incidence of repeated revascularization and stent thrombosis

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseDrug-Eluting StentsHemorrhagePercutaneous Coronary InterventionPlatelet Aggregation InhibitorsHumansCoronary ThrombosisDual Anti-Platelet TherapyProsthesis DesignRandomized Controlled Trials as TopicRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

High Bleeding Riskdrug eluting stentsmeta‐analysispercutaneous coronary intervention

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Division of Cardiology, Cardiovascular and Thoracic Department, "Città della Salute e della Scienza" Hospital, Turin, Italy.
  • Department of Medical Sciences, University of Turin, Turin, Italy.
  • Division of Cardiology, San Giovanni Bosco Hospital, ASL Città di Torino, Turin, Italy.
  • Department of Medical Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy.
  • Mediterranea Cardiocentro, Napoli, Italy.
  • Institute of Cardiology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

ORCID-Profile: Federico Giacobbe, Eduardo Valente, Ovidio De Filippo, Mario Iannaccone, Giuseppe Biondi Zoccai, Francesco Burzotta, Fabrizio D'Ascenzo

Zitieren

APA

Giacobbe, F., Valente, E., Morena, A., Nebiolo, M., Giannino, G., De Filippo, O., Bruno, F., Isaevska, E., Richiardi, L., Iannaccone, M., Zoccai, G. B., Burzotta, F., D'Ascenzo, F., & Ferrari, G. M. (2024). Safety and efficacy of drug‐eluting stents for patients at high risk of bleedings: A network meta‐analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31047

Vancouver

Giacobbe F, Valente E, Morena A, Nebiolo M, Giannino G, De Filippo O, et al. Safety and efficacy of drug‐eluting stents for patients at high risk of bleedings: A network meta‐analysis. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31047

BibTeX
@article{Giacobbe2024,
  author = {Giacobbe, Federico and Valente, Eduardo and Morena, Arianna and Nebiolo, Marco and Giannino, Giuseppe and De Filippo, Ovidio and Bruno, Francesco and Isaevska, Elena and Richiardi, Lorenzo and Iannaccone, Mario and Zoccai, Giuseppe Biondi and Burzotta, Francesco and D'Ascenzo, Fabrizio and Ferrari, Gaetano Maria De},
  title = {Safety and efficacy of drug‐eluting stents for patients at high risk of bleedings: A network meta‐analysis},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31047}
}
Kostenlos starten →